K-RAS Associated Gene-Mutation-Based Algorithm for Prediction of Treatment Response of Patients with Subtypes of Breast Cancer and Especially Triple-Negative Cancer
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: TCGA n=399 training plus MSK n=807 external test: random-forest gene-mutation combinations, 10-fold CV and external outcome discrimination; supports a specific breast-cancer response association, retrospective public cohorts.
Technology: TCGA n=399 training plus MSK n=807 external test: random-forest gene-mutation combinations, 10-fold CV and external outcome discrimination; supports a specific breast-cancer response association, retrospective public cohorts.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- TCGA n=399 training plus MSK n=807 external test: random-forest gene-mutation combinations, 10-fold CV and external outcome discrimination; supports a specific breast-cancer response association, retrospective public cohorts.
- Limitation / still unknown
- TCGA n=399 training plus MSK n=807 external test: random-forest gene-mutation combinations, 10-fold CV and external outcome discrimination; supports a specific breast-cancer response association, retrospective public cohorts. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.mdpi.com/2072-6694/14/21/5322
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.